Skip to content
2000
Volume 17, Issue 5
  • ISSN: 1570-1794
  • E-ISSN: 1875-6271

Abstract

The preparation of medicinally promising spiro1,4–dihydropyridines accompanied by their applications in biological and pharmaceutical activities is presented. Spiro1,4–dihydropyridines were synthesized using numerous reported methods including bronested acids such as p-TSA, AcOH, nano-ranged calix[4]arene tetracarboxylic acid, sulfamic acid, PEG-OSO3H, tetramethylguanidinium triflate; lewis acids including Zn(OTf)2, FeCl3, copper, alum, aluminosilicate nanoparticles, MnFe2O4 nanoparticles, manganese ferrite nanoparticles, BF3OEt2; under alkaline conditions such as Et3N and piperidine; ionic liquids such as [KAl(SO4)2·12H2O] and [Bmim]PF6, [MIM(CH2)4SO3H][HSO4]; and other miscellaneous procedures, for example, microwave-assisted catalyst and solvent-free conditions, using iodine, PEG-400, and NaCl.

Loading

Article metrics loading...

/content/journals/cos/10.2174/1570179417666200415150027
2020-08-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/cos/10.2174/1570179417666200415150027
Loading

  • Article Type:
    Review Article
Keyword(s): 4-dihydropyridines; bronested acids; heterocyclic; multi-component; one-pot; Spiro1; synthesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test